Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0574785
Disease: Lower Urinary Tract Symptoms
Lower Urinary Tract Symptoms
0.030 Biomarker phenotype BEFREE 5α-reductase inhibitor (5-ARI) is a commonly used medicine in the treatment of lower urinary tract symptoms (LUTS) associated with benign prostatic hyperplasia (BPH). 30883989 2019
CUI: C0574785
Disease: Lower Urinary Tract Symptoms
Lower Urinary Tract Symptoms
0.030 Biomarker phenotype BEFREE Treatment with 5-ARI for lower urinary tract symptoms is safe with respect to prostate cancer risk. 29548030 2018
CUI: C0574785
Disease: Lower Urinary Tract Symptoms
Lower Urinary Tract Symptoms
0.030 Biomarker phenotype BEFREE We considered for inclusion in this systematic review randomised controlled trials (RCTs) comparing PDEIs versus placebo, ABs, or 5-ARIs for at least four weeks in men with BPH-LUTS. 30480763 2018